Cochrane · systematic review · CD008475

Gonadotrophin‐releasing hormone analogues for pain associated with endometriosis

Veth, VB, van de Kar, MMA, McDonnell, R, et al. · Cochrane Database of Systematic Reviews · 2010 · Cochrane Library

Gynaecology and FertilityAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
6
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 1 · 16.7%Low 4 · 66.7%Moderate 1 · 16.7%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

GnRHas compared to No treatment for pain associated with endometriosis

Population: women with pain associated with endometriosis
1 question
OutcomeEffectEvidenceStatus / GRADE
Relief of painful symptoms ‐ Dysmenorrhoea
GnRHas vs No treatment
RR 3.93 [1.37, 11.28]1 study · 35 participantsLow
Downgraded: risk of bias

GnRHas compared to Placebo for pain associated with endometriosis

Population: women with pain associated with endometriosis
2 questions
OutcomeEffectEvidenceStatus / GRADE
Relief of painful symptoms ‐ pelvic tenderness
GnRHas vs Placebo
RR 4.17 [1.62, 10.68]1 study · 49 participantsLow
Downgraded: risk of bias
Pain score ‐ Overall at 4 weeks
GnRHas vs Placebo
no estimate extracted1 study · 120 participantsLow
Downgraded: risk of bias

GnRHas compared to Danazol for women with pain due to endometriosis

Population: women with pain due to endometriosis
2 questions
OutcomeEffectEvidenceStatus / GRADE
Relief of painful symptoms ‐ Dysmenorrhoea
GnRHas vs Danazol
RR 0.98 [0.92, 1.04]7 studies · 666 participantsVery low
Downgraded: risk of bias, inconsistency
Overall resolution ‐ Overall resolution/improvement
GnRHas vs Danazol
RR 1.1 [1.01, 1.21]9 studies · 1046 participantsLow
Downgraded: risk of bias

GnRHas compared to intra‐ uterine progestogen device for pain associated with endometriosis

Population: women with pain associated with endometriosis
1 question
OutcomeEffectEvidenceStatus / GRADE
Relief of painful symptoms ‐ Overall
GnRHas vs intra‐ uterine progestogen device
no estimate extracted3 studies · 129 participantsModerate
Downgraded: risk of bias